A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462
Clinical trial NCT06989983 · COMPLETED
Trial details
- NCT number
- NCT06989983
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-20
- Primary completion
- 2025-06-25
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.